Gary L. Wenk - Publications

Affiliations: 
Ohio State University, Columbus, Columbus, OH 
Area:
neuroinflammation
Website:
http://faculty.psy.ohio-state.edu/wenk/

153 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Lana D, Ugolini F, Wenk GL, Giovannini MG, Zecchi-Orlandini S, Nosi D. Microglial distribution, branching, and clearance activity in aged rat hippocampus are affected by astrocyte meshwork integrity: evidence of a novel cell-cell interglial interaction. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201801539R. PMID 30496700 DOI: 10.1096/fj.201801539R  0.427
2017 Lana D, Ugolini F, Nosi D, Wenk GL, Giovannini MG. Alterations in the Interplay between Neurons, Astrocytes and Microglia in the Rat Dentate Gyrus in Experimental Models of Neurodegeneration. Frontiers in Aging Neuroscience. 9: 296. PMID 28955220 DOI: 10.3389/fnagi.2017.00296  0.486
2017 Lana D, Di Russo J, Mello T, Wenk GL, Giovannini MG. Rapamycin inhibits mTOR/p70S6K activation in CA3 region of the hippocampus of the rat and impairs long term memory. Neurobiology of Learning and Memory. 137: 15-26. PMID 27838442 DOI: 10.1016/j.nlm.2016.11.006  0.371
2016 Lana D, Iovino L, Nosi D, Wenk GL, Giovannini MG. The neuron-astrocyte-microglia triad involvement in neuroinflammaging mechanisms in the CA3 hippocampus of memory-impaired aged rats. Experimental Gerontology. PMID 27466072 DOI: 10.1016/j.exger.2016.07.011  0.44
2015 Mercatelli R, Lana D, Bucciantini M, Giovannini MG, Cerbai F, Quercioli F, Zecchi-Orlandini S, Delfino G, Wenk GL, Nosi D. Clasmatodendrosis and β-amyloidosis in aging hippocampus. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 26722005 DOI: 10.1096/Fj.15-275503  0.816
2015 Adzovic L, Lynn AE, D'Angelo HM, Crockett AM, Kaercher RM, Royer SE, Hopp SC, Wenk GL. Erratum to: Insulin improves memory and reduces chronic neuroinflammation in the hippocampus of young but not aged brains. Journal of Neuroinflammation. 12: 142. PMID 26248591 DOI: 10.1186/S12974-015-0321-9  0.805
2015 Adzovic L, Lynn AE, D'Angelo HM, Crockett AM, Kaercher RM, Royer SE, Hopp SC, Wenk GL. Insulin improves memory and reduces chronic neuroinflammation in the hippocampus of young but not aged brains. Journal of Neuroinflammation. 12: 63. PMID 25889938 DOI: 10.1186/s12974-015-0282-z  0.806
2015 Hopp SC, D'Angelo HM, Royer SE, Kaercher RM, Crockett AM, Adzovic L, Wenk GL. Calcium dysregulation via L-type voltage-dependent calcium channels and ryanodine receptors underlies memory deficits and synaptic dysfunction during chronic neuroinflammation. Journal of Neuroinflammation. 12: 56. PMID 25888781 DOI: 10.1186/S12974-015-0262-3  0.818
2015 Hopp SC, Royer SE, D'Angelo HM, Kaercher RM, Fisher DA, Wenk GL. Differential neuroprotective and anti-inflammatory effects of L-type voltage dependent calcium channel and ryanodine receptor antagonists in the substantia nigra and locus coeruleus. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 10: 35-44. PMID 25318607 DOI: 10.1007/S11481-014-9568-7  0.818
2014 Hopp SC, D'Angelo HM, Royer SE, Kaercher RM, Adzovic L, Wenk GL. Differential rescue of spatial memory deficits in aged rats by L-type voltage-dependent calcium channel and ryanodine receptor antagonism. Neuroscience. 280: 10-8. PMID 25224829 DOI: 10.1016/J.Neuroscience.2014.09.007  0.805
2014 Duarte JM, Schuck PF, Wenk GL, Ferreira GC. Metabolic disturbances in diseases with neurological involvement. Aging and Disease. 5: 238-55. PMID 25110608 DOI: 10.14336/Ad.2014.0500238  0.684
2014 Hopp SC, Royer S, Brothers HM, Kaercher RM, D'Angelo H, Bardou I, Wenk GL. Age-associated alterations in the time-dependent profile of pro- and anti-inflammatory proteins within the hippocampus in response to acute exposure to interleukin-1β. Journal of Neuroimmunology. 267: 86-91. PMID 24393520 DOI: 10.1016/J.Jneuroim.2013.12.010  0.806
2014 Bardou I, Kaercher RM, Brothers HM, Hopp SC, Royer S, Wenk GL. Age and duration of inflammatory environment differentially affect the neuroimmune response and catecholaminergic neurons in the midbrain and brainstem. Neurobiology of Aging. 35: 1065-73. PMID 24315728 DOI: 10.1016/J.Neurobiolaging.2013.11.006  0.804
2014 Hopp S, Royer S, D’Angelo H, Kaercher R, Adzovic L, Crockett A, Wenk G. 129. Blockade of L-type voltage dependent calcium channels or ryanodine receptors during chronic neuroinflammation improves spatial memory and reduces expression of inflammatory markers Brain, Behavior, and Immunity. 40: e38. DOI: 10.1016/J.Bbi.2014.06.149  0.818
2013 Brothers HM, Bardou I, Hopp SC, Marchalant Y, Kaercher RM, Turner SM, Mitchem MR, Kigerl K, Wenk GL. Time-Dependent Compensatory Responses to Chronic Neuroinflammation in Hippocampus and Brainstem: The Potential Role of Glutamate Neurotransmission. Journal of Alzheimer's Disease & Parkinsonism. 3: 110. PMID 24600537 DOI: 10.4172/2161-0460.1000110  0.808
2013 Brothers HM, Bardou I, Hopp SC, Kaercher RM, Corona AW, Fenn AM, Godbout JP, Wenk GL. Riluzole partially rescues age-associated, but not LPS-induced, loss of glutamate transporters and spatial memory. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 8: 1098-105. PMID 23709339 DOI: 10.1007/S11481-013-9476-2  0.83
2013 Bardou I, Brothers HM, Kaercher RM, Hopp SC, Wenk GL. Differential effects of duration and age on the consequences of neuroinflammation in the hippocampus. Neurobiology of Aging. 34: 2293-301. PMID 23639208 DOI: 10.1016/J.Neurobiolaging.2013.03.034  0.819
2012 Cerbai F, Lana D, Nosi D, Petkova-Kirova P, Zecchi S, Brothers HM, Wenk GL, Giovannini MG. The neuron-astrocyte-microglia triad in normal brain ageing and in a model of neuroinflammation in the rat hippocampus. Plos One. 7: e45250. PMID 23028880 DOI: 10.1371/Journal.Pone.0045250  0.829
2012 Marchalant Y, Baranger K, Wenk GL, Khrestchatisky M, Rivera S. Can the benefits of cannabinoid receptor stimulation on neuroinflammation, neurogenesis and memory during normal aging be useful in AD prevention? Journal of Neuroinflammation. 9: 10. PMID 22248015 DOI: 10.1186/1742-2094-9-10  0.767
2012 Bardou I, DiPatrizio N, Brothers HM, Kaercher RM, Baranger K, Mitchem M, Hopp SC, Wenk GL, Marchalant Y. Pharmacological manipulation of cannabinoid neurotransmission reduces neuroinflammation associated with normal aging Health. 4: 679-684. DOI: 10.4236/Health.2012.429107  0.814
2011 Norman GJ, Morris JS, Karelina K, Weil ZM, Zhang N, Al-Abed Y, Brothers HM, Wenk GL, Pavlov VA, Tracey KJ, Devries AC. Cardiopulmonary arrest and resuscitation disrupts cholinergic anti-inflammatory processes: a role for cholinergic α7 nicotinic receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 3446-52. PMID 21368056 DOI: 10.1523/JNEUROSCI.4558-10.2011  0.686
2011 Brothers H, Hopp S, Bardou I, Wenk G. P3-422: Elevated glutamate transport by GLT1 attenuates inflammation-induced memory impairment Alzheimer's & Dementia. 7: S650-S650. DOI: 10.1016/J.Jalz.2011.05.1865  0.798
2011 Bardou I, Brothers H, Marchalant Y, Wenk G. P3-417: Stimulation of endocannabinoid receptors is required for reduction of neuroinflammation and restoration of neurogenesis in the aged brain Alzheimer's & Dementia. 7: S649-S649. DOI: 10.1016/j.jalz.2011.05.1860  0.68
2010 Brothers HM, Marchalant Y, Wenk GL. Caffeine attenuates lipopolysaccharide-induced neuroinflammation. Neuroscience Letters. 480: 97-100. PMID 20541589 DOI: 10.1016/j.neulet.2010.06.013  0.835
2009 Marchalant Y, Brothers HM, Wenk GL. Cannabinoid agonist WIN-55,212-2 partially restores neurogenesis in the aged rat brain. Molecular Psychiatry. 14: 1068-9. PMID 19920834 DOI: 10.1038/mp.2009.62  0.828
2009 Marchalant Y, Brothers HM, Wenk GL. New neuron production can be increased in the hippocampus of aged rats following cannabinoid treatment. Molecular Psychiatry. 14: 1067, 1068-9. PMID 19920833 DOI: 10.1038/mp.2009.122  0.807
2009 Rosi S, Ramirez-Amaya V, Vazdarjanova A, Esparza EE, Larkin PB, Fike JR, Wenk GL, Barnes CA. Accuracy of hippocampal network activity is disrupted by neuroinflammation: rescue by memantine. Brain : a Journal of Neurology. 132: 2464-77. PMID 19531533 DOI: 10.1093/brain/awp148  0.686
2009 Marchalant Y, Brothers HM, Norman GJ, Karelina K, DeVries AC, Wenk GL. Cannabinoids attenuate the effects of aging upon neuroinflammation and neurogenesis. Neurobiology of Disease. 34: 300-7. PMID 19385063 DOI: 10.1016/J.Nbd.2009.01.014  0.833
2008 Marchalant Y, Brothers HM, Wenk GL. Inflammation and aging: can endocannabinoids help? Biomedicine & Pharmacotherapy = Biomã©Decine & Pharmacothã©Rapie. 62: 212-7. PMID 18400455 DOI: 10.1016/j.biopha.2008.02.004  0.802
2008 Marchalant Y, Cerbai F, Brothers HM, Wenk GL. Cannabinoid receptor stimulation is anti-inflammatory and improves memory in old rats. Neurobiology of Aging. 29: 1894-901. PMID 17561311 DOI: 10.1016/J.Neurobiolaging.2007.04.028  0.832
2008 Brothers H, Cerbai F, Marchalant Y, Wenk G. P3-353: Regional susceptibility to inflammation: Neuron-glia interactions in the hippocampus and substantia nigra and rescue by the NMDA antagonist memantine Alzheimer's & Dementia. 4: T625-T625. DOI: 10.1016/J.Jalz.2008.05.1923  0.782
2008 Marchalant Y, Brothers HM, Wenk GL. P2-398: Role Of endocannabinoids on neuroinflammation, memory and neurogenesis in aged rats Alzheimer's & Dementia. 4: T489-T490. DOI: 10.1016/j.jalz.2008.05.1476  0.814
2007 Marriott LK, McGann-Gramling KR, Hauss-Wegrzyniak B, Sheldahl LC, Shapiro RA, Dorsa DM, Wenk GL. Estrogen replacement regimen and brain infusion of lipopolysaccharide differentially alter steroid receptor expression in the uterus and hypothalamus. Endocrine. 32: 317-28. PMID 18247162 DOI: 10.1007/s12020-008-9038-1  0.806
2007 Marchalant Y, Rosi S, Wenk GL. Anti-inflammatory property of the cannabinoid agonist WIN-55212-2 in a rodent model of chronic brain inflammation. Neuroscience. 144: 1516-22. PMID 17178196 DOI: 10.1016/j.neuroscience.2006.11.016  0.844
2007 Marriott LK, McGann-Gramling KR, Hauss-Wegrzyniak B, Sheldahl LC, Shapiro RA, Dorsa DM, Wenk GL. Brain infusion of lipopolysaccharide increases uterine growth as a function of estrogen replacement regimen: suppression of uterine estrogen receptor-alpha by constant, but not pulsed, estrogen replacement. Endocrinology. 148: 232-40. PMID 17023524 DOI: 10.1210/en.2006-0642  0.804
2006 Rosi S, Vazdarjanova A, Ramirez-Amaya V, Worley PF, Barnes CA, Wenk GL. Memantine protects against LPS-induced neuroinflammation, restores behaviorally-induced gene expression and spatial learning in the rat. Neuroscience. 142: 1303-15. PMID 16989956 DOI: 10.1016/j.neuroscience.2006.08.017  0.755
2006 Wenk GL, Parsons CG, Danysz W. Potential role of N-methyl-D-aspartate receptors as executors of neurodegeneration resulting from diverse insults: focus on memantine. Behavioural Pharmacology. 17: 411-24. PMID 16940762 DOI: 10.1097/00008877-200609000-00007  0.425
2006 Marchalant Y, Rosi S, Wenk GL. P4-420: Anti-inflammatory actions of the endocannabinoid system in a rodent model of chronic neuroinflammation Alzheimer's & Dementia. 2: S641-S642. DOI: 10.1016/j.jalz.2006.05.2162  0.792
2005 Rosi S, Pert CB, Ruff MR, McGann-Gramling K, Wenk GL. Chemokine receptor 5 antagonist D-Ala-peptide T-amide reduces microglia and astrocyte activation within the hippocampus in a neuroinflammatory rat model of Alzheimer's disease. Neuroscience. 134: 671-6. PMID 15979806 DOI: 10.1016/j.neuroscience.2005.04.029  0.679
2005 Rosi S, Ramirez-Amaya V, Vazdarjanova A, Worley PF, Barnes CA, Wenk GL. Neuroinflammation alters the hippocampal pattern of behaviorally induced Arc expression. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 723-31. PMID 15659610 DOI: 10.1523/JNEUROSCI.4469-04.2005  0.749
2004 Wenk GL. Assessment of spatial memory using the radial arm maze and Morris water maze. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit 8.5A. PMID 18428607 DOI: 10.1002/0471142301.ns0805as26  0.341
2004 Gasparini L, Ongini E, Wenk G. Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action. Journal of Neurochemistry. 91: 521-36. PMID 15485484 DOI: 10.1111/J.1471-4159.2004.02743.X  0.347
2004 Mohmmad Abdul H, Wenk GL, Gramling M, Hauss-Wegrzyniak B, Butterfield DA. APP and PS-1 mutations induce brain oxidative stress independent of dietary cholesterol: implications for Alzheimer's disease. Neuroscience Letters. 368: 148-50. PMID 15351438 DOI: 10.1016/J.Neulet.2004.06.077  0.696
2004 Rosi S, Ramirez-Amaya V, Hauss-Wegrzyniak B, Wenk GL. Chronic brain inflammation leads to a decline in hippocampal NMDA-R1 receptors. Journal of Neuroinflammation. 1: 12. PMID 15285803 DOI: 10.1186/1742-2094-1-12  0.818
2004 Wenk GL, McGann-Gramling K, Hauss-Wegrzyniak B. The presence of the APP(swe) mutation in mice does not increase the vulnerability of cholinergic basal forebrain neurons to neuroinflammation. Neuroscience. 125: 769-76. PMID 15099690 DOI: 10.1016/j.neuroscience.2004.01.050  0.737
2004 Wenk GL, McGann-Gramling K, Hauss-Wegrzyniak B, Ronchetti D, Maucci R, Rosi S, Gasparini L, Ongini E. Attenuation of chronic neuroinflammation by a nitric oxide-releasing derivative of the antioxidant ferulic acid. Journal of Neurochemistry. 89: 484-93. PMID 15056291 DOI: 10.1111/J.1471-4159.2004.02359.X  0.783
2004 Wrenn CC, Kinney JW, Marriott LK, Holmes A, Harris AP, Saavedra MC, Starosta G, Innerfield CE, Jacoby AS, Shine J, Iismaa TP, Wenk GL, Crawley JN. Learning and memory performance in mice lacking the GAL-R1 subtype of galanin receptor. The European Journal of Neuroscience. 19: 1384-96. PMID 15016096 DOI: 10.1111/J.1460-9568.2004.03214.X  0.692
2004 Marriott LK, Wenk GL. Neurobiological consequences of long-term estrogen therapy Current Directions in Psychological Science. 13: 173-176. DOI: 10.1111/j.0963-7214.2004.00301.x  0.641
2004 Ongini E, McGann-Gramling K, Hauss-Wegrzyniak B, Ronchetti D, Maucci R, Rosi S, Gasparini L, Wenk GL. P4-214 A nitric oxide-releasing derivative of the antioxidant ferulic acid, NCX 2057, attenuates chronic neuroinflammation in rat Neurobiology of Aging. 25: S536. DOI: 10.1016/S0197-4580(04)81772-X  0.781
2004 He T, Chen K, Reiman EM, Hicks C, Trouard T, Galons J, Hauss-Wegrzyniak B, Stevenson GD, Valla J, Wenk GL, Alexander GE. P2-192 The computation of mannitol-induced changes in mouse brain volume using sequential MRI and an iterative principal component analysis Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)80938-2  0.691
2004 Rosi S, Pert CB, Ruff MR, Gremling KM, Wenk GL. P1-359 DAPTA targets CCR5 chemokine receptors and suppresses microglial activation in a neuroinflammatory rat model of Alzheimer's disease Neurobiology of Aging. 25: S200. DOI: 10.1016/S0197-4580(04)80671-7  0.638
2004 Wenk GL, McGann-Gramling KR, Hauss-Wegrzyniak B, Marriott LK. O3-04-01 Neurobiological consequences of chronic and variable estrogen therapy in the presence of long term neuroinflammation Neurobiology of Aging. 25: S59. DOI: 10.1016/S0197-4580(04)80199-4  0.765
2003 Wenk GL, McGann K, Hauss-Wegrzyniak B, Rosi S. The toxicity of tumor necrosis factor-alpha upon cholinergic neurons within the nucleus basalis and the role of norepinephrine in the regulation of inflammation: implications for Alzheimer's disease. Neuroscience. 121: 719-29. PMID 14568031 DOI: 10.1016/S0306-4522(03)00545-1  0.786
2003 Rogawski MA, Wenk GL. The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease. Cns Drug Reviews. 9: 275-308. PMID 14530799 DOI: 10.1111/J.1527-3458.2003.Tb00254.X  0.387
2003 Rosi S, McGann K, Hauss-Wegrzyniak B, Wenk GL. The influence of brain inflammation upon neuronal adenosine A2B receptors. Journal of Neurochemistry. 86: 220-7. PMID 12807441 DOI: 10.1046/j.1471-4159.2003.01825.x  0.821
2003 Woodruff-Pak DS, Vogel RW, Wenk GL. Mecamylamine interactions with galantamine and donepezil: effects on learning, acetylcholinesterase, and nicotinic acetylcholine receptors. Neuroscience. 117: 439-47. PMID 12614684 DOI: 10.1016/S0306-4522(02)00872-2  0.301
2002 Wrenn CC, Marriott LK, Kinney JW, Holmes A, Wenk GL, Crawley JN. Galanin peptide levels in hippocampus and cortex of galanin-overexpressing transgenic mice evaluated for cognitive performance. Neuropeptides. 36: 413-26. PMID 12507436 DOI: 10.1016/S0143-4179(02)00111-7  0.712
2002 Wenk GL, Rosi S, McGann K, Hauss-Wegrzyniak B. A nitric oxide-donating flurbiprofen derivative reduces neuroinflammation without interacting with galantamine in the rat. European Journal of Pharmacology. 453: 319-24. PMID 12398920 DOI: 10.1016/S0014-2999(02)02387-7  0.816
2002 Marriott LK, Hauss-Wegrzyniak B, Benton RS, Vraniak PD, Wenk GL. Long-term estrogen therapy worsens the behavioral and neuropathological consequences of chronic brain inflammation. Behavioral Neuroscience. 116: 902-11. PMID 12369809 DOI: 10.1037//0735-7044.116.5.902  0.824
2002 Hauss-Wegrzyniak B, Lynch MA, Vraniak PD, Wenk GL. Chronic brain inflammation results in cell loss in the entorhinal cortex and impaired LTP in perforant path-granule cell synapses. Experimental Neurology. 176: 336-41. PMID 12359175 DOI: 10.1006/exnr.2002.7966  0.738
2002 Hauss-Wegrzyniak B, Wenk GL. Beta-amyloid deposition in the brains of rats chronically infused with thiorphan or lipopolysaccharide: the role of ascorbic acid in the vehicle. Neuroscience Letters. 322: 75-8. PMID 11958847 DOI: 10.1016/S0304-3940(02)00087-3  0.711
2002 Jantzen PT, Connor KE, DiCarlo G, Wenk GL, Wallace JL, Rojiani AM, Coppola D, Morgan D, Gordon MN. Microglial activation and beta -amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 2246-54. PMID 11896164 DOI: 10.1523/Jneurosci.22-06-02246.2002  0.314
2001 Wenk GL. Assessment of spatial memory. Current Protocols in Toxicology / Editorial Board, Mahin D. Maines (Editor-in-Chief) ... [Et Al.]. Unit11.3. PMID 20957640 DOI: 10.1002/0471140856.tx1103s00  0.339
2001 Wenk GL. Assessment of spatial memory using the T maze. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit 8.5B. PMID 18428543 DOI: 10.1002/0471142301.ns0805bs04  0.335
2001 Woodruff-Pak DS, Vogel RW, Wenk GL. Galantamine: effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning. Proceedings of the National Academy of Sciences of the United States of America. 98: 2089-94. PMID 11172080 DOI: 10.1073/pnas.031584398  0.331
2000 Wenk GL, Barnes CA. Regional changes in the hippocampal density of AMPA and NMDA receptors across the lifespan of the rat. Brain Research. 885: 1-5. PMID 11121523 DOI: 10.1016/S0006-8993(00)02792-X  0.563
2000 Willard LB, Hauss-Wegrzyniak B, Danysz W, Wenk GL. The cytotoxicity of chronic neuroinflammation upon basal forebrain cholinergic neurons of rats can be attenuated by glutamatergic antagonism or cyclooxygenase-2 inhibition. Experimental Brain Research. 134: 58-65. PMID 11026726 DOI: 10.1007/s002210000446  0.827
2000 Hauss-Wegrzyniak B, Galons JP, Wenk GL. Quantitative volumetric analyses of brain magnetic resonance imaging from rat with chronic neuroinflammation. Experimental Neurology. 165: 347-54. PMID 10993694 DOI: 10.1006/exnr.2000.7469  0.736
2000 Wenk GL, McGann K, Mencarelli A, Hauss-Wegrzyniak B, Del Soldato P, Fiorucci S. Mechanisms to prevent the toxicity of chronic neuroinflammation on forebrain cholinergic neurons. European Journal of Pharmacology. 402: 77-85. PMID 10940360 DOI: 10.1016/S0014-2999(00)00523-9  0.768
2000 Barnes CA, Meltzer J, Houston F, Orr G, McGann K, Wenk GL. Chronic treatment of old rats with donepezil or galantamine: effects on memory, hippocampal plasticity and nicotinic receptors. Neuroscience. 99: 17-23. PMID 10924948 DOI: 10.1016/S0306-4522(00)00180-9  0.606
2000 Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, ... ... Wenk G, et al. Inflammation and Alzheimer's disease. Neurobiology of Aging. 21: 383-421. PMID 10858586 DOI: 10.1016/S0197-4580(00)00124-X  0.362
2000 Hauss-Wegrzyniak B, Vraniak PD, Wenk GL. LPS-induced neuroinflammatory effects do not recover with time. Neuroreport. 11: 1759-63. PMID 10852239 DOI: 10.1097/00001756-200006050-00032  0.768
2000 Wenk GL, Quack G, Moebius HJ, Danysz W. No interaction of memantine with acetylcholinesterase inhibitors approved for clinical use. Life Sciences. 66: 1079-83. PMID 10737358 DOI: 10.1016/S0024-3205(00)00411-2  0.339
2000 Hauss-Wegrzyniak B, Vannucchi MG, Wenk GL. Behavioral and ultrastructural changes induced by chronic neuroinflammation in young rats. Brain Research. 859: 157-66. PMID 10720625 DOI: 10.1016/S0006-8993(00)01999-5  0.794
2000 Wenk GL, Del Soldato P, Hauss-Wegyzyniak B, Danysz W. An investigation of mechanisms to prevent the cytotoxicity of chronic neuroinflammation upon basal forebrain cholinergic neurons in young rats Neurobiology of Aging. 21: 226. DOI: 10.1016/S0197-4580(00)83351-5  0.412
1999 Hauss-Wegrzyniak B, Vraniak P, Wenk GL. The effects of a novel NSAID on chronic neuroinflammation are age dependent. Neurobiology of Aging. 20: 305-13. PMID 10588578 DOI: 10.1016/S0197-4580(99)00028-7  0.786
1999 Wenk GL, Hauss-Wegrzyniak B. Altered cholinergic function in the basal forebrain of girls with Rett syndrome. Neuropediatrics. 30: 125-9. PMID 10480206 DOI: 10.1055/s-2007-973476  0.716
1999 Willard LB, Hauss-Wegrzyniak B, Wenk GL. Pathological and biochemical consequences of acute and chronic neuroinflammation within the basal forebrain cholinergic system of rats. Neuroscience. 88: 193-200. PMID 10051200 DOI: 10.1016/S0306-4522(98)00216-4  0.823
1999 Hauss-Wegrzyniak B, Willard LB, Del Soldato P, Pepeu G, Wenk GL. Peripheral administration of novel anti-inflammatories can attenuate the effects of chronic inflammation within the CNS. Brain Research. 815: 36-43. PMID 9974120 DOI: 10.1016/S0006-8993(98)01081-6  0.813
1998 Wenk GL, Willard LB. The neural mechanisms underlying cholinergic cell death within the basal forebrain. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 16: 729-35. PMID 10198820 DOI: 10.1016/S0736-5748(98)00081-1  0.792
1998 Wenk GL, Baker LM, Hauss-Wegrzyniak B, Danysz W, Stoehr JD. Novel glycineB antagonists show neuroprotective activity in vivo. Amino Acids. 14: 223-6. PMID 9871465 DOI: 10.1007/BF01345266  0.738
1998 Wenk GL, Baker LM, Stoehr JD, Hauss-Wegrzyniak B, Danysz W. Neuroprotection by novel antagonists at the NMDA receptor channel and glycineB sites. European Journal of Pharmacology. 347: 183-7. PMID 9653879 DOI: 10.1016/S0014-2999(98)00112-5  0.727
1998 McDonald MP, Willard LB, Wenk GL, Crawley JN. Coadministration of galanin antagonist M40 with a muscarinic M1 agonist improves delayed nonmatching to position choice accuracy in rats with cholinergic lesions. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 5078-85. PMID 9634573 DOI: 10.1523/Jneurosci.18-13-05078.1998  0.805
1998 Hauss-Wegrzyniak B, Dobrzanski P, Stoehr JD, Wenk GL. Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease. Brain Research. 780: 294-303. PMID 9507169 DOI: 10.1016/S0006-8993(97)01215-8  0.789
1998 Baker L, Hauss-Wegrzyniak B, Wenk G. The effect of a novel NO-NSAID on chronic neuroinflammation Journal of Neuroimmunology. 90: 79. DOI: 10.1016/S0165-5728(98)91653-8  0.717
1997 McDonald MP, Wenk GL, Crawley JN. Analysis of galanin and the galanin antagonist M40 on delayed non-matching-to-position performance in rats lesioned with the cholinergic immunotoxin 192 IgG-saporin. Behavioral Neuroscience. 111: 552-63. PMID 9189270 DOI: 10.1037/0735-7044.111.3.552  0.368
1997 Stoehr JD, Mobley SL, Roice D, Brooks R, Baker LM, Wiley RG, Wenk GL. The effects of selective cholinergic basal forebrain lesions and aging upon expectancy in the rat. Neurobiology of Learning and Memory. 67: 214-27. PMID 9159760 DOI: 10.1006/nlme.1997.3768  0.363
1997 Wenk GL. Rett syndrome: neurobiological changes underlying specific symptoms. Progress in Neurobiology. 51: 383-91. PMID 9106898 DOI: 10.1016/S0301-0082(96)00059-7  0.332
1997 Wenk GL. The nucleus basalis magnocellularis cholinergic system: one hundred years of progress. Neurobiology of Learning and Memory. 67: 85-95. PMID 9075237 DOI: 10.1006/nlme.1996.3757  0.304
1997 Wenk GL, Zajaczkowski W, Danysz W. Neuroprotection of acetylcholinergic basal forebrain neurons by memantine and neurokinin B. Behavioural Brain Research. 83: 129-33. PMID 9062671 DOI: 10.1016/S0166-4328(97)86056-1  0.427
1996 Shen J, Barnes CA, Wenk GL, McNaughton BL. Differential effects of selective immunotoxic lesions of medial septal cholinergic cells on spatial working and reference memory. Behavioral Neuroscience. 110: 1181-6. PMID 8919021 DOI: 10.1037//0735-7044.110.5.1181  0.568
1996 Wenk GL, Danysz W, Roice DD. The effects of mitochondrial failure upon cholinergic toxicity in the nucleus basalis. Neuroreport. 7: 1453-6. PMID 8856696 DOI: 10.1097/00001756-199606170-00001  0.351
1996 Wenk GL, Stoehr JD, Mobley SL, Gurney J, Morris RJ. Age-related decrease in vulnerability to excitatory amino acids in the nucleus basalis. Neurobiology of Aging. 17: 1-7. PMID 8786791 DOI: 10.1016/0197-4580(95)02025-X  0.386
1996 Wenk GL, Mobley SL. Choline acetyltransferase activity and vesamicol binding in Rett syndrome and in rats with nucleus basalis lesions. Neuroscience. 73: 79-84. PMID 8783231 DOI: 10.1016/0306-4522(96)00019-X  0.395
1996 Robinson JK, Wenk GL, Wiley RG, Lappi DA, Crawley JN. 192IgG-Saporin immunotoxin and ibotenic acid lesions of nucleus basalis and medial septum produce comparable deficits on delayed nonmatching to position in rats Psychobiology. 24: 179-186. DOI: 10.3758/Bf03327034  0.388
1995 Wenk GL. Neuroprotection and selective vulnerability of neurons within the nucleus basalis magnocellularis. Behavioural Brain Research. 72: 17-24. PMID 8788852 DOI: 10.1016/0166-4328(96)00152-0  0.307
1995 Wenk GL, Danysz W, Mobley SL. MK-801, memantine and amantadine show neuroprotective activity in the nucleus basalis magnocellularis. European Journal of Pharmacology. 293: 267-70. PMID 8666045 DOI: 10.1016/0926-6917(95)00028-3  0.382
1995 Wenk GL, Rance NE, Mobley SL. Effects of excitatory amino acid lesions upon neurokinin B and acetylcholine neurons in the nucleus basalis of the rat. Brain Research. 679: 8-14. PMID 7544224 DOI: 10.1016/0006-8993(95)00187-U  0.394
1995 Stoehr JD, Wenk GL. Effects of age and lesions of the nucleus basalis on contextual fear conditioning Psychobiology. 23: 173-177. DOI: 10.3758/BF03332019  0.358
1994 Harrington CA, Mobley SL, Wenk GL. Nitric oxide formation does not underlie the memory deficits produced by ibotenate injections into the nucleus basalis of rats. Behavioral Neuroscience. 108: 277-83. PMID 8037871 DOI: 10.1037//0735-7044.108.2.277  0.417
1994 Ragozzino ME, Wenk GL, Gold PE. Glucose attenuates a morphine-induced decrease in hippocampal acetylcholine output: an in vivo microdialysis study in rats. Brain Research. 655: 77-82. PMID 7812793 DOI: 10.1016/0006-8993(94)91599-7  0.31
1994 Wenk GL, Danysz W, Mobley SL. Investigations of neurotoxicity and neuroprotection within the nucleus basalis of the rat. Brain Research. 655: 7-11. PMID 7812791 DOI: 10.1016/0006-8993(94)91590-3  0.367
1994 Wenk GL, Stoehr JD, Quintana G, Mobley S, Wiley RG. Behavioral, biochemical, histological, and electrophysiological effects of 192 IgG-saporin injections into the basal forebrain of rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 14: 5986-95. PMID 7523630 DOI: 10.1523/Jneurosci.14-10-05986.1994  0.398
1993 Wenk GL, O'Leary M, Nemeroff CB, Bissette G, Moser H, Naidu S. Neurochemical alterations in Rett syndrome. Brain Research. Developmental Brain Research. 74: 67-72. PMID 8403377 DOI: 10.1016/0165-3806(93)90084-N  0.333
1993 Wenk GL. A primate model of Alzheimer's disease. Behavioural Brain Research. 57: 117-22. PMID 8117419 DOI: 10.1016/0166-4328(93)90127-C  0.377
1993 Ricaurte GA, Markowska AL, Wenk GL, Hatzidimitriou G, Wlos J, Olton DS. 3,4-Methylenedioxymethamphetamine, serotonin and memory. The Journal of Pharmacology and Experimental Therapeutics. 266: 1097-105. PMID 8102642  0.532
1993 Moyse E, Szigethy E, Danger JM, Vaudry H, Wenk GL, Beaudet A, Epelbaum J. Short- and long-term effects of nucleus basalis magnocellularis lesions on cortical levels of somatostatin and its receptors in the rat. Brain Research. 607: 154-60. PMID 8097661 DOI: 10.1016/0006-8993(93)91501-I  0.356
1993 Davis S, Markowska AL, Wenk GL, Barnes CA. Acetyl-L-carnitine: behavioral, electrophysiological, and neurochemical effects. Neurobiology of Aging. 14: 107-15. PMID 8095700 DOI: 10.1016/0197-4580(93)90030-F  0.601
1992 Stone WS, Wenk GL, Stone SM, Gold PE. Glucose attenuation of paradoxical sleep deficits in old rats. Behavioral and Neural Biology. 57: 79-86. PMID 1348925 DOI: 10.1016/0163-1047(92)90779-4  0.316
1992 Wenk GL, Harrington CA, Tucker DA, Rance NE, Walker LC. Basal forebrain neurons and memory: a biochemical, histological, and behavioral study of differential vulnerability to ibotenate and quisqualate. Behavioral Neuroscience. 106: 909-23. PMID 1282013 DOI: 10.1037/0735-7044.106.6.909  0.426
1992 Harrington CA, Wenk GL. Differential vulnerability of basal forebrain cholinergic and NADPH diaphorase cells to ibotenate and quisqualate Psychobiology. 20: 254-260. DOI: 10.3758/BF03332057  0.371
1991 Olton DS, Markowska A, Breckler SJ, Wenk GL, Pang KC, Koliatsos V. Individual differences in aging: behavioral and neural analyses. Biomedical and Environmental Sciences : Bes. 4: 166-72. PMID 1910593  0.56
1991 Olton D, Markowska A, Voytko ML, Givens B, Gorman L, Wenk G. Basal forebrain cholinergic system: a functional analysis. Advances in Experimental Medicine and Biology. 295: 353-72. PMID 1776577 DOI: 10.1007/978-1-4757-0145-6_20  0.571
1991 Aigner TG, Mitchell SJ, Aggleton JP, DeLong MR, Struble RG, Price DL, Wenk GL, Pettigrew KD, Mishkin M. Transient impairment of recognition memory following ibotenic-acid lesions of the basal forebrain in macaques. Experimental Brain Research. 86: 18-26. PMID 1756788 DOI: 10.1007/Bf00231036  0.337
1991 Wenk GL, Naidu S, Casanova MF, Kitt CA, Moser H. Altered neurochemical markers in Rett's syndrome. Neurology. 41: 1753-6. PMID 1658685 DOI: 10.1212/Wnl.41.11.1753  0.311
1991 Markowska AL, Wenk GL. Serotonin influences the behavioral recovery of rats following nucleus basalis lesions. Pharmacology, Biochemistry, and Behavior. 38: 731-7. PMID 1651515 DOI: 10.1016/0091-3057(91)90234-S  0.411
1991 Wenk GL, Walker LC, Price DL, Cork LC. Loss of NMDA, but not GABA-A, binding in the brains of aged rats and monkeys. Neurobiology of Aging. 12: 93-8. PMID 1646968 DOI: 10.1016/0197-4580(91)90047-N  0.417
1990 Sakurai Y, Wenk GL. The interaction of acetylcholinergic and serotonergic neural systems on performance in a continuous non-matching to sample task. Brain Research. 519: 118-21. PMID 2397399 DOI: 10.1016/0006-8993(90)90068-M  0.368
1990 Stone WS, Wenk GL, Olton DS, Gold PE. Poor blood glucose regulation predicts sleep and memory deficits in normal aged rats. Journal of Gerontology. 45: B169-73. PMID 2394910 DOI: 10.1093/Geronj/45.5.B169  0.598
1990 Spangler EL, Wenk GL, Chachich ME, Smith K, Ingram DK. Complex maze performance in rats: effects of noradrenergic depletion and cholinergic blockade. Behavioral Neuroscience. 104: 410-7. PMID 2354036 DOI: 10.1037/0735-7044.104.3.410  0.372
1990 Markowska AL, Wenk GL, Olton DS. Nucleus basalis magnocellularis and memory: differential effects of two neurotoxins. Behavioral and Neural Biology. 54: 13-26. PMID 2198869 DOI: 10.1016/0163-1047(90)91211-S  0.641
1989 Wenk GL, Olton DS. Cognitive enhancers: potential strategies and experimental results. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 13: S117-39. PMID 2694226 DOI: 10.1016/0278-5846(89)90115-2  0.559
1989 Wenk GL. An hypothesis on the role of glucose in the mechanism of action of cognitive enhancers. Psychopharmacology. 99: 431-8. PMID 2687922 DOI: 10.1007/BF00589888  0.305
1989 Wenk GL, Markowska AL, Olton DS. Basal forebrain lesions and memory: alterations in neurotensin, not acetylcholine, may cause amnesia. Behavioral Neuroscience. 103: 765-9. PMID 2669837 DOI: 10.1037/0735-7044.103.4.765  0.639
1989 Markowska AL, Stone WS, Ingram DK, Reynolds J, Gold PE, Conti LH, Pontecorvo MJ, Wenk GL, Olton DS. Individual differences in aging: behavioral and neurobiological correlates. Neurobiology of Aging. 10: 31-43. PMID 2569170 DOI: 10.1016/S0197-4580(89)80008-9  0.619
1989 Wenk GL, Pierce DJ, Struble RG, Price DL, Cork LC. Age-related changes in multiple neurotransmitter systems in the monkey brain. Neurobiology of Aging. 10: 11-9. PMID 2569169 DOI: 10.1016/S0197-4580(89)80005-3  0.349
1989 Wenk GL, Grey CM, Ingram DK, Spangler EL, Olton DS. Retention of maze performance inversely correlates with N-methyl-D-aspartate receptor number in hippocampus and frontal neocortex in the rat. Behavioral Neuroscience. 103: 688-90. PMID 2544208 DOI: 10.1037/0735-7044.103.3.688  0.619
1989 Crawley JN, Wenk GL. Co-existence of galanin and acetylcholine: is galanin involved in memory processes and dementia? Trends in Neurosciences. 12: 278-82. PMID 2475942 DOI: 10.1016/0166-2236(89)90003-9  0.38
1988 Olton DS, Wenk GL, Church RM, Meck WH. Attention and the frontal cortex as examined by simultaneous temporal processing. Neuropsychologia. 26: 307-18. PMID 3399046 DOI: 10.1016/0028-3932(88)90083-8  0.717
1988 Wenk GL. Amnesia and Alzheimer's disease: which neurotransmitter system is responsible? Neurobiology of Aging. 9: 640-1. PMID 2905431 DOI: 10.1016/S0197-4580(88)80126-X  0.371
1988 Szigethy E, Wenk GL, Beaudet A. Anatomical substrate for neurotensin-acetylcholine interactions in the rat basal forebrain. Peptides. 9: 1227-34. PMID 2854624 DOI: 10.1016/0196-9781(88)90186-6  0.303
1988 Wenk GL, Rökaeus A. Basal forebrain lesions differentially alter galanin levels and acetylcholinergic receptors in the hippocampus and neocortex. Brain Research. 460: 17-21. PMID 2464403 DOI: 10.1016/0006-8993(88)90425-8  0.376
1988 Peternel A, Hughey D, Wenk G, Olton D. Basal forebrain and memory: Neurotoxic lesions impair serial reversals of a spatial discrimination Psychobiology. 16: 54-58. DOI: 10.3758/BF03327299  0.631
1987 Hohmann GF, Wenk GL, Lowenstein P, Brown ME, Coyle JT. Age-related recurrence of basal forebrain lesion-induced cholinergic deficits. Neuroscience Letters. 82: 253-9. PMID 3696497 DOI: 10.1016/0304-3940(87)90265-5  0.413
1987 Meck WH, Church RM, Wenk GL, Olton DS. Nucleus basalis magnocellularis and medial septal area lesions differentially impair temporal memory. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 7: 3505-11. PMID 3681402 DOI: 10.1523/Jneurosci.07-11-03505.1987  0.691
1987 Raffaele K, Hughey D, Wenk G, Olton D, Modrow H, McDonough J. Long-term behavioral changes in rats following organophosphonate exposure. Pharmacology, Biochemistry, and Behavior. 27: 407-12. PMID 3659063 DOI: 10.1016/0091-3057(87)90341-8  0.618
1987 Aigner TG, Mitchell SJ, Aggleton JP, DeLong MR, Struble RG, Price DL, Wenk GL, Mishkin M. Effects of scopolamine and physostigmine on recognition memory in monkeys with ibotenic-acid lesions of the nucleus basalis of Meynert. Psychopharmacology. 92: 292-300. PMID 3114781 DOI: 10.1007/BF00210833  0.377
1987 Wenk G, Hughey D, Boundy V, Kim A, Walker L, Olton D. Neurotransmitters and memory: role of cholinergic, serotonergic, and noradrenergic systems. Behavioral Neuroscience. 101: 325-32. PMID 2886134 DOI: 10.1037/0735-7044.101.3.325  0.624
1986 Wenk GL, Engisch KL, McCall LD, Mitchell SJ, Aigner TG, Struble RL, Price DL, Olton DS. [(3)H]ketanserin binding increases in monkey cortex following basal forebrain lesions with ibotenic acid. Neurochemistry International. 9: 557-62. PMID 20493162 DOI: 10.1016/0197-0186(86)90150-6  0.579
1986 Meck WH, Church RM, Wenk GL. Arginine vasopressin innoculates against age-related increases in sodium-dependent high affinity choline uptake and discrepancies in the content of temporal memory. European Journal of Pharmacology. 130: 327-31. PMID 3792454 DOI: 10.1016/0014-2999(86)90287-6  0.652
1986 Wenk G, Sweeney J, Hughey D, Carson J, Olton D. Cholinergic function and memory: extensive inhibition of choline acetyltransferase fails to impair radial maze performance in rats. Pharmacology, Biochemistry, and Behavior. 25: 521-6. PMID 3774818 DOI: 10.1016/0091-3057(86)90134-6  0.656
1986 Wenk GL, Engisch KL. [3H]ketanserin (serotonin type 2) binding increases in rat cortex following basal forebrain lesions with ibotenic acid. Journal of Neurochemistry. 47: 845-50. PMID 2942641 DOI: 10.1111/J.1471-4159.1986.Tb00688.X  0.354
1986 Wenk GL, Engisch KL, McCall LD, Mitchell SJ, Aigner TG, Struble RL, Price DL, Olton DS. [3H]ketanserin binding increases in monkey cortex following basal forebrain lesions with ibotenic acid Neurochemistry International. 9: 557-562. DOI: 10.1016/0197-0186(86)90150-6  0.487
1985 Hepler DJ, Wenk GL, Cribbs BL, Olton DS, Coyle JT. Memory impairments following basal forebrain lesions. Brain Research. 346: 8-14. PMID 4052773 DOI: 10.1016/0006-8993(85)91088-1  0.607
1985 Knowlton BJ, Wenk GL, Olton DS, Coyle JT. Basal forebrain lesions produce a dissociation of trial-dependent and trial-independent memory performance. Brain Research. 345: 315-21. PMID 4041891 DOI: 10.1016/0006-8993(85)91008-X  0.584
1985 Hepler DJ, Olton DS, Wenk GL, Coyle JT. Lesions in nucleus basalis magnocellularis and medial septal area of rats produce qualitatively similar memory impairments. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 5: 866-73. PMID 4038997 DOI: 10.1523/Jneurosci.05-04-00866.1985  0.623
1985 Hepler D, Wenk G, Olton D, Coyle J. Lesions in nucleus basalis magnocellularis and medial septal area of rats produce similar memory impairments in appetitive and non-appetitive behavioral tasks. Annals of the New York Academy of Sciences. 444: 518-9. PMID 3860114 DOI: 10.1111/J.1749-6632.1985.Tb37631.X  0.617
1984 Wenk GL, Olton DS. Recovery of neocortical choline acetyltransferase activity following ibotenic acid injection into the nucleus basalis of Meynert in rats. Brain Research. 293: 184-6. PMID 6704718 DOI: 10.1016/0006-8993(84)91468-9  0.606
1984 Wenk G, Suzuki K. Congenital copper deficiency: copper therapy and dopamine-beta-hydroxylase activity in the mottled (brindled) mouse. Journal of Neurochemistry. 41: 1648-52. PMID 6644305 DOI: 10.1111/J.1471-4159.1983.Tb00876.X  0.43
1984 Wenk G, Hepler D, Olton D. Behavior alters the uptake of [3H]choline into acetylcholinergic neurons of the nucleus basalis magnocellularis and medial septal area. Behavioural Brain Research. 13: 129-38. PMID 6487403 DOI: 10.1016/0166-4328(84)90143-8  0.626
1984 Wenk GL, Cribbs B, McCall L. Nucleus basalis magnocellularis: optimal coordinates for selective reduction of choline acetyltransferase in frontal neocortex by ibotenic acid injections. Experimental Brain Research. 56: 335-40. PMID 6479267 DOI: 10.1007/BF00236289  0.31
1984 Wenk GL. Pharmacological manipulations of the substantia innominata-cortical cholinergic pathway. Neuroscience Letters. 51: 99-103. PMID 6151154 DOI: 10.1016/0304-3940(84)90269-6  0.342
1983 Wenk GL, Stemmer KL. Suboptimal dietary zinc intake increases aluminum accumulation into the rat brain. Brain Research. 288: 393-5. PMID 6661634 DOI: 10.1016/0006-8993(83)90127-0  0.339
Show low-probability matches.